Ingilterra - Ingliż - MHRA (Medicines & Healthcare Products Regulatory Agency)

accord-uk ltd - bisoprolol fumarate - oral tablet - 10mg

Awstralja - Ingliż - Department of Health (Therapeutic Goods Administration)

avallon pharmaceuticals pty ltd - bisoprolol fumarate, quantity: 5 mg - tablet, film coated - excipient ingredients: magnesium stearate; microcrystalline cellulose; croscarmellose sodium; iron oxide yellow; calcium hydrogen phosphate; colloidal anhydrous silica; pregelatinised maize starch; titanium dioxide; lactose monohydrate; hypromellose; macrogol 4000 - treatment of stable chronic moderate to severe heart failure in addition to ace inhibitors, and diuretics, and optionally cardiac glycosides.

Awstralja - Ingliż - Department of Health (Therapeutic Goods Administration)

avallon pharmaceuticals pty ltd - bisoprolol fumarate, quantity: 2.5 mg - tablet, film coated - excipient ingredients: croscarmellose sodium; pregelatinised maize starch; microcrystalline cellulose; calcium hydrogen phosphate; colloidal anhydrous silica; magnesium stearate; titanium dioxide; lactose monohydrate; hypromellose; macrogol 4000 - treatment of stable chronic moderate to severe heart failure in addition to ace inhibitors, and diuretics, and optionally cardiac glycosides.

Awstralja - Ingliż - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - bisoprolol fumarate, quantity: 5 mg - tablet - excipient ingredients: microcrystalline cellulose; lactose monohydrate; crospovidone; magnesium stearate; iron oxide yellow - treatment of stable chronic moderate to severe heart failure in addition to ace inhibitors and diuretics and, optionally, cardiac glycosides.

Awstralja - Ingliż - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - bisoprolol fumarate, quantity: 2.5 mg - tablet - excipient ingredients: lactose monohydrate; magnesium stearate; microcrystalline cellulose; crospovidone - treatment of stable chronic moderate to severe heart failure in addition to ace inhibitors and diuretics and, optionally, cardiac glycosides.

Awstralja - Ingliż - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - bisoprolol fumarate, quantity: 5 mg - tablet, film coated - excipient ingredients: calcium hydrogen phosphate; hypromellose; colloidal anhydrous silica; magnesium stearate; iron oxide yellow; dimeticone 100; titanium dioxide; microcrystalline cellulose; maize starch; crospovidone; macrogol 400 - treatment of stable chronic moderate to severe heart failure in addition to ace inhibitors, and diuretics, and optionally cardiac glycosides.

Awstralja - Ingliż - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - bisoprolol fumarate, quantity: 2.5 mg - tablet, film coated - excipient ingredients: hypromellose; crospovidone; titanium dioxide; dimeticone 100; magnesium stearate; colloidal anhydrous silica; calcium hydrogen phosphate; macrogol 400; maize starch; microcrystalline cellulose - treatment of stable chronic moderate to severe heart failure in addition to ace inhibitors, and diuretics, and optionally cardiac glycosides.

Awstralja - Ingliż - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - bisoprolol fumarate, quantity: 5 mg - tablet - excipient ingredients: microcrystalline cellulose; sodium starch glycollate type a; croscarmellose sodium; magnesium stearate; colloidal anhydrous silica - treatment of stable chronic moderate to severe heart failure in addition to ace inhibitors, and diuretics, and optionally cardiac glycosides.

Awstralja - Ingliż - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - bisoprolol fumarate, quantity: 2.5 mg - tablet - excipient ingredients: croscarmellose sodium; colloidal anhydrous silica; sodium starch glycollate type a; microcrystalline cellulose; magnesium stearate - treatment of stable chronic moderate to severe heart failure in addition to ace inhibitors, and diuretics, and optionally cardiac glycosides.

Awstralja - Ingliż - Department of Health (Therapeutic Goods Administration)

strides pharma science pty ltd - bisoprolol fumarate, quantity: 7.5 mg - tablet, film coated - excipient ingredients: microcrystalline cellulose; magnesium stearate; crospovidone; calcium hydrogen phosphate; colloidal anhydrous silica; titanium dioxide; hypromellose; macrogol 400 - treatment of stable chronic moderate to severe heart failure in addition to ace inhibitors, and diuretics, and optionally cardiac glycosides.